Alnylam Pharmaceuticals Inc

NASDAQ:ALNY   9:33:46 AM EDT
137.02
-1.29 (-0.93%)
Earnings Announcements

Alnylam Says Achieved FY 2021 Preliminary Global Net Product Revenues Of $662 Mln

Published: 01/09/2022 18:09 GMT
Alnylam Pharmaceuticals Inc (ALNY) - Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates.
Alnylam Pharmaceuticals-achieved Full Year 2021 Preliminary Global Net Product Revenues of $662 Million, Representing 83% Annual Growth Compared to 2020.
Revenue is expected to be $226.42 Million
Adjusted EPS is expected to be -$1.60

Next Quarter Revenue Guidance is expected to be $253.95 Million
Next Quarter EPS Guidance is expected to be -$1.28

More details on our Analysts Page.